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Abstract

There is conflicting evidence regarding the effect of AT1 receptor antagonists on
learning and memory processes. The effects of angiotensin II and losartan administration
into CA1 hippocampal area on the avoidance performance in olfactory bulbectomized
(OBX) rats using active avoidance (shuttle box) test and passive avoidance (step through)
test were investigated. Rats were microinjected unilaterally through implanted guide
cannulas into the CA1 area of the dorsal hippocampus and the drugs were administered
separately, 5 minutes before each training session. The microinjections of losartan into the
left, but not the right CA1 hippocampal area improved the acquisition and retention of
active and passive avoidance learning, thus suggesting dependence on the side of injection.
The unilateral (left or right) administration of angiotensin II did not significantly affect the
performance of OBX rats in the avoidance tasks. A differential distribution of the AT1
receptors in the left and right hemisphere could contribute for the asymmetry in the
behavioral effects of the AT receptor antagonist.

Keywords: angiotensin II, losartan, learning, memory, asymmetry, hippocampus,
olfactory bulbectomy
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Introduction

microinjections

of

Ang

II

into

the

CA1

The octapeptide angiotensin II (Ang II) is a hippocampal area (9- 11).
potent effector hormone of the renin-angiotensin
system (RAS). The brain has its own intrinsic RAS
and most of its components are expressed in the
central nervous system. The brain RAS includes
the biologically active angiotensin peptides: Ang
II, Ang III, Ang IV and Ang-(1-7) (1). Four
receptor types have been proposed within the RAS:
the Ang II type 1 and 2 receptors (AT1, AT2), Ang
IV-specific

receptor(AT4),

and

Ang-(1–7)

selective receptor (2- 4). The AT1 and AT2 types
are

structurally

similar,

G-protein

coupled

receptors. The AT4 receptor is a protein, which is
not G-protein-linked, while Ang-(1–7) exerts its
actions via the G protein-coupled Mas receptor.

The role of Ang II in brain pathology is
poorly understood and not widely studied. Ang II
has

been

suggested

to

participate

in

the

pathophysiology of stress, Alzheimer's disease and
depression. The first evidence that brain RAS may
be involved in depressive disorder was observed in
hypertensive

patients

undergoing

captopril

treatment (12). Investigations demonstrated that
high angiotensin-converting enzyme activity led to
high Ang II formation, which was associated with
depression,

hypothalamic-pituitary

axis

hyperactivity and anxiety (13-15). It was found
that the blockage of angiotensin II synthesis with
angiotensin-converting enzyme inhibitors (ACEI)

The hippocampus is a part of the limbic in transgenic rats with high production of brain
system, which is important for cognitive processes. Ang II reduces the increased anxiety (16, 17).
Both the concentration of Ang II and the There is increasing evidence indicating beneficial
expression of angiotensin receptors are particularly effects of angiotensin II receptor blockers (ARBs)
high in the hippocampus and the CA1 hippocampal in brain disorders such as stroke, Alzheimer's
neurons are reported to be sensitive to Ang II (5, disease, depression and stress (18). In an
6). Ang II being a part of the brain RAS, acts as a experimental study, the AT1 antagonist losartan
neurotransmitter or a neuromodulator. Increasing improved depression-like behavior in mice, as
evidence supports the involvement of Ang II and determined by the forced swim test (19). Clinical
its receptors in learning and memory processes, research demonstrated that the treatment with
although the behavioral consequences apparently ARBs decreases anxiety and depression in patients
depend upon the methods, doses and location of (20, 21). The ACEI led to similar therapeutic
the treatment (7-9). Previous studies have found effects - improved the efficacy of antidepressants
behavioral asymmetries (in locomotor activity, and
anxiety,

learning

and

memory)

decreased

anxiety

and

depression

in

following normotensive rats (22, 23).

40

Tashev ER. et al.

Olfactory bulbectomy (OBX) provides a
well-validated animal model of depression. It is
considered

most

neurochemical

suitable

for

mechanisms

studying

underlying

the
the

pathophysiology of depression. Bilateral removal
of the olfactory bulbs in rats induces a syndrome of
behavioral deficits that reflect a disruption of
cortical and limbic regions, accompanied by
neurochemical, endocrine and immune alterations,
reminiscent of symptoms of human depression (24,
25).

OBX

leads

to

extensive

cognitive

impairments, with deficits in learning and memory

Materials and methods
Animals
Male Wistar rats (200 – 220 g, 2 month old at
the time of surgery) were housed individually in
polypropylene boxes with free access to food and
water. The animals were maintained in a constant
temperature environment (22 ± 2°C) on a 12h
light/dark cycle (lights on at 6.00 am). The
behavior experiments were carried out between
10:00 am and 1:00 pm. After the testing procedure,
the rats were returned to their respective home
cages.

(24, 26, 27). Borre et al. and Douma et al. have
suggested that OBX in rats can serve also as an

The experiments were performed according

animal model of neurodegeneration (28, 29). to the “Rules for care and experiments on
According to Yehuda and Rabinovitz, OBX laboratory animals” of the Ethics Committee of the
mimics a complex of Alzheimer’s symptoms, Institute of Neurobiology, Bulgarian Academy of
including cognitive decline, increased locomotor Sciences. All efforts were made to minimize
activity, decreased food intake, etc. (30). The animal suffering and reduce the number of animals
neurodegeneration of the septo-hippocampal used in the study.
cholinergic pathways (31), which accompany

Surgical procedures

memory impairments and the elevation of amyloid
beta level in the brain (32) also point to the
usefulness of OBX as an animal model of
Alzheimer’s disease.

Bilateral olfactory bulbectomy was carried
out according to the method described by Kelly et
al. (24). Seven days after bilateral olfactory
bulbectomy a cannula was surgically implanted

Bearing in mind the above considerations, the into the CA1 hippocampal area as described
aim of our study was to examine the effects of Ang previously (9).
II and the AT1 receptor antagonist losartan on
learning and memory processes after unilateral
application into CA1 hippocampal area in OBX
rats.

Behavioral methods
The animals were tested in a two-way active
avoidance test (shuttle box) and a passive
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avoidance

test

(step-through)

as

described of injection (F2,

previously (7).

35=8,402,

P≤0.001). On the

2ndtraining day ANOVA demonstrated significant
effects for the factors “drug“ (F2,35 = 32,439, P ≤

Statistical analysis

0.001), “side“ (F1,35 = 19.756, P ≤ 0.001) and a
Separate two-factor analysis of variance
(ANOVA) was used to analyze the data obtained
for the number of avoidances (shuttle-box) in the
learning test (1st and 2nd training day) and the
memory test (24 h after the 2nd training day)
between subject factors: drug (three levels: Ang II,
losartan or saline) and side of injection (two levels:

significant interaction between the factors “drug”×
“side “ (F1,35 = 18.756, P ≤ 0.001). At the retention
test ANOVA revealed a significance for “drug“
(F2,35 = 25.833, P ≤ 0.001), side of injection (F1,35
= 15,873, P ≤ 0.001) and a significant interaction
between “drug” × “side” (F2,35 = 18,373; P ≤

left and right). ANOVA data were analyzed further 0.001).
by

post-hoc

Student-Newman–Keuls

(SNK).

Post-hoc SNK comparisons demonstrated

Analysis of the passive avoidance data was that losartan infused into CA1 area produced
performed using χ2 tests.
significantly greater number of avoidances when
Results

injected into the left CA1 area on 1st day
(P  0.001), 2nd day (P  0.001) and at the

Shuttle box test

retention test (P  0.001), as compared to the

The bilateral removal of the olfactory bulbs respective saline-treated OBX-controls (Fig. 1A,
resulted in an impairment of the learning and B, C). Microinjected into the right side, losartan
memory in the active avoidance task (shuttle did not affect significantly the number of
box).The number of avoidances of rats with avoidances on the training days and at the retention
developed depression was significantly lower as test (Fig. 1A, B, C).Upon left-side or right-side
compared to the sham-operated controls on the 1st administration, Ang II did not significantly affect
the number of avoidances, as compared to the
training day (P  0.001), 2nd training day (P 
respective OBX saline-treated controls during the
0.001) and on the retention test (P  0.001) (Fig.
whole experimental period(Fig. 1A, B, C).
1A, B, C).Two way ANOVA demonstrated
significant effects for the factors “drug” (Ang II

The unilateral injection of losartan showed a

and losartan) on the number of avoidances (F2,35= clear lateralized improvement of learning and
13,819, P<0.001)and “side” of injection (F1,35= memory. Microinjected into the left CA1 area
8.533, P≤ 0.04) on the 1sttraining day. There was losartan increased significantly the number of
also significant interaction between “drug”×“side” avoidances

as

compared

to

the

right-side
42
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injections: on the 1sttraining day (P ≤ 0.001), on rats that reached the learning criteria on the 3rdh
the 2ndday (P ≤ 0.001) and at the retention test(P ≤ (50%)and on the 24th h(63%).Losartan infused into
0.001) (Fig. 1A, B, C).

the right side did not affect the performance of the
OBX rats in the step-through task (Fig. 2A, B).The

Step through test

injection of losartan into the left CA1 area
One way ANOVA on the latent time of OBX increased significantly the latent time on the 3rdh
rats showed a significant effect on the retention (P ≤ 0.001) and 24th h (P ≤ 0.001) as compared to
tests: on the 3rd h after training (F1,11 = 155,702; the right-side infusions (Fig. 2A, B). The effect of
P ≤ 0.001) and on the 24th after training (F1,11 Ang II administered unilaterally (left- or right side)
= 218,256; P ≤ 0.001). At the passive avoidance did not differ significantly from the respective
task, bulbectomized rats demonstrated a significant saline treated OBX controls (Fig. 2A, B).
decrease of the latent time on the retention tests: on
the 3rd h (P ≤ 0.001) and on the 24th (P ≤ 0.001) as

Discussion

compared to the sham-OBX group. The number of

The bilateral olfactory bulbectomy markedly

OBX rats fulfilling the learning criteria diminished impaired the performance of rats in both avoidance
to 0%,as compared to the sham operated controls tasks compared to the sham-operated controls, as
which reached50%learning criteria on the 3rdh and has been reported previously (24, 27). Our results
63% on the 24th h (Fig. 1A, B). Separate two way showed a lateralized ameliorating effect of the
ANOVA demonstrated significant effects of the AT1 receptor antagonist losartan on learning and
factors “drug”(F2,47 = 45,014; P ≤ 0.001) and memory deficits in OBX rats. The microinjections
“side”(F1,47= 42,103, P≤ 0.04)for the 3rdhThere of losartan into the left but not the right CA1
was

also

“drug”×“side”

significant
of

interaction

injection

between hippocampal area improved the acquisition and

(F2,47=34,715, retention of active and passive avoidance learning,

P≤0.001). At the retention test ANOVA showed thus suggesting dependence on the side of
significance for “drug“ (F2,47 =150,410, P ≤ 0.001), injection. In addition, the unilateral (left or right)
“side “ (F1,47 = 115,394, P ≤ 0.001), as well as a administration of angiotensin II did not affect
significant interaction between “drug” × “side” significantly the performance of OBX rats in the
(F2,47 = 118,530; P ≤ 0.001).
Post hoc test showed that the microinjection

avoidance tasks.
Studies have shown controversial results

of losartan into the left CA1 area prolonged the about the effects centrally administered AngII on
latency time on the 3rdh (P ≤ 0.001) and on the 24th learning and memory processes. In the avoidance
h (P ≤ 0.001) and increased the percentage of the paradigms, used to evaluate learning and memory
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of

rodents,

it

has

been

observed

that prior to training. Hence, it was concluded that the

intracerebroventricular (i.c.v.) injection of Ang II decrease in endogenous Ang II activity in the brain
impairs (34), improves (35-37), or has no effect might result in improved cognitive performance
(38)

on

the

cognitive

performance.

The (43).

administration of Ang II into CA1 hippocampal
area in a step-down inhibitory avoidance task
produced a dose-dependent amnesic effect, which
was blocked by the AT2 receptor antagonist, PD
123319, but not by the AT1 receptor antagonist
losartan (39, 40). The conﬂicting results about the
cognitive effects of Ang II can be explained by the
fact that these effects are very sensitive to the

There are many reports about the beneficial
effects of AT1 blockers in different experimental
models of learning and memory impairments.
DeNoble et al. showed that the impaired
performance on a passive avoidance task in rats
treated i.c.v. with renin could be offset with ACEI
treatment, or by the application of the AT1

different methodological approaches (time interval receptor antagonists (44). Orally administered
between the injection of Ang II and the performing telmisartan (AT1 receptor blocker) improved
of the test, type of administration, differences in spatial learning and memory in a type 1 diabetic
dosage, duration of treatment, number of training mouse model, streptozotocin-induced diabetic
sessions, and type of memory task evaluated).
Concerning the type of receptors involved in
the effects of Ang II on cognitive processes, data
are contradictory too. Braszko reported that both

mice (45), while pretreatment with a nonhypotensive dose of telmisartan significantly
inhibited cognitive decline in an experimental
model of Alzheimer disease (46). Inaba et al.

AT1 and AT2 receptors may contribute to the demonstrated that olmesartan (another AT1
effects of Ang II in passive avoidance, object blocker) diminished the cognitive alterations
recognition and active avoidance tests, with an observed ina shuttle-box avoidance task for the
exception of lack of influence of AT1 receptor human renin and human angiotensinogen gene
inhibition on active avoidance acquisition (41), chimeric transgenic mice and suggested that
while other authors (37, 42) observed no effect of continuous activation of the brain RAS impairs
centrally applied losartan on active avoidance tests. cognitive function via stimulation of AT1 receptor
By comparing the effect of captopril (ACEI)

(47). Clinical data with Ang II antagonists tend to

and losartan (a selective AT1 receptor antagonist) support experimental findings. It has been shown
in an active avoidance task, Raghavendra et al. that losartan improves cognitive functions in
found that both drugs were equally effective in hypertensive patients as well as in normotensive
enhancing retention of memory when administered adults (48, 49).
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Our results showed no effects of Ang II on

Angiotensin II type 1 (AT1) receptor

the avoidance behavior of OBX rats. Previously, blockers have shown powerful neuroprotective
using the same experimental protocol, Belcheva et effects in vivo (56, 57). The latest research
al. reported that Ang II infused into CA1 area provided evidence that ARBs may protect the brain
enhanced acquisition and retention in a two-way from different types of injury resulting in
active avoidance test (9). The bilateral removal of parenchyma inflammation and neuronal damage.
the olfactory bulbs results in neurodegeneration in Beneﬁcial effects on memory functions for the
the projection areas of the bulbs such as cortex, AT1 receptor blockers have been demonstrated in
amygdala and hippocampus (25). Although data traumatic

animal

models.

For

example,

are lacking about the expression of RAS candesartan treatment reduced the lesion volume
components in the brain of OBX rats, the after controlled cortical impact injury on mice and
neurodegenerative changes might be accompanied improved performance in the Morris water maze 4
with abnormalities in RAS in different brain weeks after injury (58). The AT1 blockers
regions, similarly to the observed alterations on candesartan

and

telmisartan

exhibited

AT receptors in patients with neurodegenerative neuroprotective and anti-inflammatory effects in
disorders (50, 51). It could be suggested that the different models of brain injury in rodents (58- 61).
neurodegenerative changes in the hippocampus The
and

the

following

compensatory

systemic

administration

of

candesartan

neuronal decreased the acute brain inflammatory response to

reorganization could explain the lack of effects of a bacterial endotoxin lipopolysaccharide and
angiotensin II on the performance of OBX rats.
The improvement of memory deficits after
injection of losartan into CA1 area in OBX rats
may be related to its neuroprotective, antiinflammatory

and

anti-oxidant

effects.

Neurodegenerative changes, inflammation and
oxidative stress were found to play role in the
etiology of OBX-induced depression. Increased

reduced the inflammatory reaction by decreasing
the

production

of

cytokines

and

other

inflammatory factors in the brain cortex (62, 63).
The anti-inflammatory effects were widespread,
occurring

in

many

limbic

areas

such

as

hypothalamus, prefrontal cortex, hippocampus, and
amygdala.
Left–right asymmetries of brain and behavior

production of oxygen reactive species, saturation are widespread among both vertebrates and
of antioxidant enzymes, lipid peroxidation and invertebrates.

Knowledge

of

the

bilateral

generation of pro-inflammatory cytokines in the distribution of a system in brain is important to
brain of OBX rats have been reported (52- 55).

appropriately understand how it functions in health
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and pathology. Data have accumulated concerning
anatomical,

functional

and

Our results are in line with the reports about

neurochemical asymmetry in the effects of drugs acting on

asymmetries in the rat brain. The research on the angiotensin receptors. Belchevaet al. observed
impact of hippocampal left–right asymmetry on lateralization in the effects of angiotensin II,
higher-order brain functions using “split-brain” injected into the CA1 area of rats, where left-side
mice have shown that the usage of the right administration enhanced acquisition and retention
hippocampus improves the accuracy of spatial in an active avoidance task (9). Previous research
memory,

while

performance

of

other of our laboratory also demonstrated lateralized

hippocampus-dependent tasks (fear conditioning) memory enhancing effects of Ang IV and Ang II
was not influenced by the laterality of the after pretreatment with losartan in the CA1 area (7,
hippocampus (64). Recently, a dissociation of 68).
hippocampal long-term memory function between
hemispheres has been reported, suggesting that
memory is routed via distinct left–right pathways
within the mouse hippocampus (65).

Based on the above-mentioned findings, we
suggest that the lateralized ameliorative effect of
losartan on learning and memory in OBX rats
could be attributed to a hemispheric asymmetry in

Other evidence regarding the lateralization in the

components

of

the

hippocampal

RAS,

the expression of different components of RAS has including the expression and/or activity of
been provided by the research of Wu et al., who different peptides, enzymes and receptors.
found asymmetrical distribution of angiotensinase
activity in the amygdala, hippocampus and
prefrontal

cortex

of

the

rat

(66).

The

aminopeptidases (APs) termed angiotensinases are
involved in

the metabolism

of angiotensin

peptides. In the hippocampus, there was a left
predominance for AlaAP, CysAP and AspAP
activities, while GluAP predominated in the right
hippocampus (66, 67). It was also suggested that
the asymmetric activity of angiotensinases in the

In

conclusion,

our

study demonstrated

lateralized beneficial effects of losartan, injected
into the CA1 hippocampal area, on learning and
memory

deficits

induced

by

the

olfactory

bulbectomy in rats. Ang II did not affect the
behavior of OBX rats tested in the avoidance
paradigms. A differential distribution of the AT1
receptors in the left and right hemisphere could
contribute for the asymmetry in the behavioral
effects of the AT receptor antagonist.

rat hippocampus might be associated with both the
direction

and

the

intensity

of

behavioral

lateralization as expressed by paw preference (66).
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